Cardio3 BioSciences is developing an optimal cell transplant solution for curing cardiovascular diseases and, in particular, heart failure. The complete solution is composed of two products : C-CureTM and C-CathTM. C-CureTM is the first bio-therapeutic designed from autologous stem cells committed to a cardiac lineage before implantation. C-CathTM is a proprietary catheter that allows for the accurate transmyocardial injection of C-CureTM.